MOUNTAINEER Study: An Effective Treatment Combination For Metastatic Colorectal Cancer
By Oncology Brothers - Last Updated: March 1, 2023In this podcast episode, the Oncology Brothers (Drs. Rohit & Rahul Gosain) are joined by Dr. Tanios Bekaii-Saab, Mayo Clinic Comprehensive Cancer Center, to discuss the MOUNTAINEER Phase II study, which prompted the FDA approval of tucatinib in combination with trastuzumab in treating advanced colorectal cancer HER2 positive patients.
Related Posts
The Oncology Brothers spoke with a world-renowned authority in gastrointestinal malignancies to discuss colon cancer.
The Oncology Brothers highlight three studies from the recent American Association for Cancer Research (AACR) 2023 ...
The Oncology Brothers are joined by Dr. Margaret Gatti-Mays, of the Ohio State Comprehensive Cancer Center, to cover the ...
In this engaging episode, The Oncology Brothers welcome Dr. Jason Mouabbi, a breast medical oncologist from the MD ...
The Oncology Brothers are joined by Dr. Paolo Tarantino, European Institute of Oncology, Clinical Research Fellow at ...
670 Madison Ave.
Manalapan, NJ 07726